Ingalls & Snyder »

United Therapeutics Corporation shares owned by Ingalls & Snyder

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Ingalls & Snyder from 13F filings

Historical chart of Ingalls & Snyder investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Ingalls & Snyder consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Ingalls & Snyder

Quarter filed Position value Share count Share price at filing
2025-12-31 $214k 440 486.36

More positions owned by Ingalls & Snyder

Corcept Therapeutics Call Call Option (CORT)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Microsoft Corporation (MSFT)
Pan American Silver Corp Can (PAAS)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Williams Companies (WMB)
Canadian Nat Res Call Call Option (CNQ)
Exxon Mobil Corporation (XOM)
JPMorgan Chase & Co. (JPM)
Omeros Corporation (OMER)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
NVIDIA Corporation (NVDA)
Expedia Group Com New (EXPE)

View all positions for Ingalls & Snyder

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Geode Capital Management
AQR Capital Management
Assetmark
Invesco
Norges Bank Investment Management
Dimensional Fund Advisors
Susquehanna International
Henderson Group
Citadel Advisors

View all funds holding United Therapeutics Corporation